Gail L. Matters

2.2k total citations
53 papers, 1.7k citations indexed

About

Gail L. Matters is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Gail L. Matters has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Gail L. Matters's work include Neuroendocrine Tumor Research Advances (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Photosynthetic Processes and Mechanisms (8 papers). Gail L. Matters is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Photosynthetic Processes and Mechanisms (8 papers). Gail L. Matters collaborates with scholars based in United States, United Kingdom and Australia. Gail L. Matters's co-authors include Judith Bond, John G. Scandalios, Mark Kester, Christopher O. McGovern, Samuel I. Beale, Jill P. Smith, Thomas Abraham, Charles D. Boyer, James H. Adair and S I Beale and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

Gail L. Matters

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail L. Matters United States 28 739 414 329 314 228 53 1.7k
Catherine Boisson‐Vidal France 27 791 1.1× 202 0.5× 207 0.6× 232 0.7× 124 0.5× 54 2.3k
Mauro S.G. Pavão Brazil 31 1.2k 1.7× 175 0.4× 373 1.1× 204 0.6× 111 0.5× 81 3.2k
Toshiaki Ohara Japan 23 634 0.9× 600 1.4× 323 1.0× 339 1.1× 170 0.7× 113 1.7k
George W. Yip Singapore 22 1.1k 1.5× 359 0.9× 491 1.5× 114 0.4× 130 0.6× 72 2.2k
Yuwen Zhang China 28 1.7k 2.4× 344 0.8× 430 1.3× 280 0.9× 202 0.9× 74 2.5k
Jie Gao China 24 910 1.2× 251 0.6× 296 0.9× 135 0.4× 235 1.0× 90 1.7k
Chao Dong China 27 1.4k 1.8× 407 1.0× 435 1.3× 430 1.4× 172 0.8× 112 2.5k
Zheng Cui China 24 1.7k 2.2× 172 0.4× 352 1.1× 315 1.0× 234 1.0× 67 2.8k
Qing Jiang China 31 2.1k 2.8× 382 0.9× 219 0.7× 264 0.8× 118 0.5× 82 3.0k
Wenfang Wang China 25 1.2k 1.6× 220 0.5× 182 0.6× 205 0.7× 115 0.5× 98 2.3k

Countries citing papers authored by Gail L. Matters

Since Specialization
Citations

This map shows the geographic impact of Gail L. Matters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail L. Matters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail L. Matters more than expected).

Fields of papers citing papers by Gail L. Matters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail L. Matters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail L. Matters. The network helps show where Gail L. Matters may publish in the future.

Co-authorship network of co-authors of Gail L. Matters

This figure shows the co-authorship network connecting the top 25 collaborators of Gail L. Matters. A scholar is included among the top collaborators of Gail L. Matters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail L. Matters. Gail L. Matters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bussard, Karen M., Welley Siu Loc, Zi‐Kui Liu, et al.. (2021). Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts. Nanomedicine Nanotechnology Biology and Medicine. 34. 102383–102383. 5 indexed citations
2.
Abraham, Thomas, et al.. (2021). Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer. International Journal of Nanomedicine. Volume 16. 2297–2309. 15 indexed citations
3.
Moore, John H., Walter Varhue, Todd E. Fox, et al.. (2019). Conductance-Based Biophysical Distinction and Microfluidic Enrichment of Nanovesicles Derived from Pancreatic Tumor Cells of Varying Invasiveness. Analytical Chemistry. 91(16). 10424–10431. 35 indexed citations
4.
Loc, Welley Siu, Gail L. Matters, Christopher O. McGovern, et al.. (2017). Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer. Nanomedicine Nanotechnology Biology and Medicine. 13(7). 2313–2324. 12 indexed citations
5.
Matters, Gail L., et al.. (2016). Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer. Clinical and Translational Gastroenterology. 7(1). e134–e134. 4 indexed citations
6.
Clawson, Gary A., Gail L. Matters, Ping Xin, et al.. (2015). Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients. PLoS ONE. 10(8). e0134320–e0134320. 79 indexed citations
7.
Matters, Gail L., Timothy K. Cooper, Christopher O. McGovern, et al.. (2014). Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat. Digestive Diseases and Sciences. 59(6). 1180–1191. 30 indexed citations
8.
Smith, Jill P., John F. Harms, Gail L. Matters, et al.. (2012). A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer. Cancer Biology & Therapy. 13(3). 164–174. 15 indexed citations
9.
Banerjee, Sanjita, D P Jewell, Gail L. Matters, et al.. (2009). MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunology. 2(3). 220–231. 56 indexed citations
10.
Hanson, Robert L., Weiping Jiang, Gail L. Matters, et al.. (2005). Meprin β metalloprotease gene polymorphisms associated with diabetic nephropathy in the Pima Indians. Human Genetics. 118(1). 12–22. 27 indexed citations
11.
Bond, Judith, et al.. (2005). Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Letters. 579(15). 3317–3322. 65 indexed citations
12.
Bertenshaw, Greg P., Benjamin E. Turk, Simon J. Hubbard, et al.. (2001). Marked Differences between Metalloproteases Meprin A and B in Substrate and Peptide Bond Specificity. Journal of Biological Chemistry. 276(16). 13248–13255. 93 indexed citations
13.
Jiang, Weiping, et al.. (2000). Structure of the mouse metalloprotease meprin β gene (Mep1b): Alternative splicing in cancer cells. Gene. 248(1-2). 77–87. 8 indexed citations
14.
15.
Matters, Gail L. & Judith Bond. (1999). Expression and regulation of the meprin ? gene in human cancer cells. Molecular Carcinogenesis. 25(3). 169–178. 35 indexed citations
16.
17.
Im, Chung-soon, Gail L. Matters, & Samuel I. Beale. (1996). Calcium and Calmodulin Are Involved in Blue Light Induction of the gsa Gene for an Early Chlorophyll Biosynthetic Step in Chlamydomonas. The Plant Cell. 8(12). 2245–2245. 4 indexed citations
18.
Matters, Gail L. & S I Beale. (1995). Blue-Light-Regulated Expression of Genes for Two Early Steps of Chlorophyll Biosynthesis in Chlamydomonas reinhardtii. PLANT PHYSIOLOGY. 109(2). 471–479. 39 indexed citations
19.
20.
Matters, Gail L. & John G. Scandalios. (1986). Changes in plant gene expression during stress. Developmental Genetics. 7(4). 167–175. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Boisson‐Vidal Breakdown of academic impact, for papers by Mauro S.G. Pavão Breakdown of academic impact, for papers by Toshiaki Ohara Breakdown of academic impact, for papers by George W. Yip Breakdown of academic impact, for papers by Yuwen Zhang Breakdown of academic impact, for papers by Jie Gao Breakdown of academic impact, for papers by Chao Dong Breakdown of academic impact, for papers by Zheng Cui Breakdown of academic impact, for papers by Qing Jiang Breakdown of academic impact, for papers by Wenfang Wang
Rankless by CCL
2026